HEADER VIRAL PROTEIN 15-APR-15 2N1R TITLE NMR STRUCTURE OF THE MYRISTYLATED FELINE IMMUNODEFICIENCY VIRUS MATRIX TITLE 2 PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: MATRIX PROTEIN P15; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: FELINE IMMUNODEFICIENCY VIRUS (ISOLATE SOURCE 3 PETALUMA); SOURCE 4 ORGANISM_COMMON: FIV; SOURCE 5 ORGANISM_TAXID: 11674; SOURCE 6 STRAIN: PETALUMA STRAIN; SOURCE 7 VARIANT: CLONE 34TF10; SOURCE 8 GENE: GAG; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 11 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) RIL; SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 13 EXPRESSION_SYSTEM_VECTOR: PET11/PET17 KEYWDS MYRISTOYLATED, FIV, HIV, SIV, FELINE, MATRIX, P15, VIRAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR L.A.BROWN,C.COX,R.J.BUTTON,J.BAPTISTE,K.BAHLOW,V.SPURRIER,B.G.LUTTGE, AUTHOR 2 L.KUO,E.O.FREED,M.F.SUMMERS,J.KYSER,H.R.SUMMERS REVDAT 3 14-JUN-23 2N1R 1 REMARK REVDAT 2 21-DEC-22 2N1R 1 JRNL REMARK SEQADV LINK REVDAT 1 27-MAY-15 2N1R 0 JRNL AUTH L.A.BROWN,C.COX,J.BAPTISTE,H.SUMMERS,R.BUTTON,K.BAHLOW, JRNL AUTH 2 V.SPURRIER,J.KYSER,B.G.LUTTGE,L.KUO,E.O.FREED,M.F.SUMMERS JRNL TITL NMR STRUCTURE OF THE MYRISTYLATED FELINE IMMUNODEFICIENCY JRNL TITL 2 VIRUS MATRIX PROTEIN. JRNL REF VIRUSES V. 7 2210 2015 JRNL REFN ESSN 1999-4915 JRNL PMID 25941825 JRNL DOI 10.3390/V7052210 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRVIEW, CYANA REMARK 3 AUTHORS : JOHNSON, ONE MOON SCIENTIFIC (NMRVIEW) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURES WERE CALCULATED IN TORSION REMARK 3 ANGLE SPACE WITH CYANA (HTTP://WWW.LAS.JP/INDEX_EG.HTML) REMARK 3 STARTING FROM RANDOM INITIAL ANGLES. UPPER INTERPROTON DISTANCE REMARK 3 BOUNDS OF 2.7, 3.3 AND 5.0 AE (WITH APPROPRIATE CORRECTIONS FOR REMARK 3 PSEUDOATOMS) WERE EMPLOYED FOR NOE CROSS PEAKS OF STRONG, MEDIUM, REMARK 3 AND WEAK INTENSITY RESPECTIVELY, WHICH WERE QUALITATIVELY REMARK 3 DETERMINED FOLLOWING INTENSITY NORMALIZATION OF THE DIFFERENT REMARK 3 NOE DATA SETS. RESIDUAL DIPOLAR COUPLINGS WERE PROHIBITED DUE TO REMARK 3 PRECIPITATION OF THE SAMPLE. NO BACKBONE HYDROGEN BOND OR REMARK 3 CHEMICAL SHIFT-BASED TORSION ANGLE RESTRAINTS WERE EMPLOYED. REMARK 4 REMARK 4 2N1R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-APR-15. REMARK 100 THE DEPOSITION ID IS D_1000104312. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 7 REMARK 210 IONIC STRENGTH : 150MM NACL REMARK 210 PRESSURE : AMBIENT, 1ATM ATM REMARK 210 SAMPLE CONTENTS : 50 MM SODIUM PHOSPHATE, 150 MM REMARK 210 SODIUM CHLORIDE, 10 MM DTT, 1 G/ REMARK 210 L [U-99% 15N] AMMONIUM CHLORIDE, REMARK 210 4 G/L GLUCOSE, 0.5 MG/ML REMARK 210 MYRISTIC ACID, 50 MM SODIUM REMARK 210 PHOSPHATE, 150 MM SODIUM REMARK 210 CHLORIDE, 10 MM DTT, 1 G/L REMARK 210 AMMONIUM CHLORIDE, 4 G/L GLUCOSE, REMARK 210 0.5 MG/ML [U-100% 13C] MYRISTIC REMARK 210 ACID, 90% H2O, 10% D2O; 50 MM REMARK 210 SODIUM PHOSPHATE, 150 MM SODIUM REMARK 210 CHLORIDE, 10 MM DTT, 4 G/L [U- REMARK 210 100% 13C] GLUCOSE, 1 G/L REMARK 210 AMMONIUM CHLORIDE, 0.5 MG/ML REMARK 210 MYRISTIC ACID, 50 MM SODIUM REMARK 210 PHOSPHATE, 150 MM SODIUM REMARK 210 CHLORIDE, 10 MM DTT, 4 G/L [U- REMARK 210 100% 13C] GLUCOSE, 1 G/L [U-99% REMARK 210 15N] AMMONIUM CHLORIDE, 0.5 MG/ REMARK 210 ML MYRISTIC ACID, 50 MM SODIUM REMARK 210 PHOSPHATE, 150 MM SODIUM REMARK 210 CHLORIDE, 10 MM DTT, 4 G/L REMARK 210 GLUCOSE, 1 G/L AMMONIUM CHLORIDE, REMARK 210 0.5 MG/ML MYRISTIC ACID, 100% REMARK 210 D2O; 50 MM SODIUM PHOSPHATE, 150 REMARK 210 MM SODIUM CHLORIDE, 10 MM DTT, 4 REMARK 210 G/L [U-100% 13C] GLUCOSE, 1 G/L REMARK 210 AMMONIUM CHLORIDE, 0.5 MG/ML REMARK 210 MYRISTIC ACID, 50 MM SODIUM REMARK 210 PHOSPHATE, 150 MM SODIUM REMARK 210 CHLORIDE, 10 MM DTT, 4 G/L [U- REMARK 210 100% 13C] GLUCOSE, 1 G/L [U-99% REMARK 210 15N] AMMONIUM CHLORIDE, 0.5 MG/ REMARK 210 ML MYRISTIC ACID, 50 MM SODIUM REMARK 210 PHOSPHATE, 150 MM SODIUM REMARK 210 CHLORIDE, 10 MM DTT, 4 G/L REMARK 210 GLUCOSE, 1 G/L AMMONIUM CHLORIDE, REMARK 210 0.5 MG/ML MYRISTIC ACID, 100% REMARK 210 D2O; 50 MM SODIUM PHOSPHATE, 150 REMARK 210 MM SODIUM CHLORIDE, 10 MM DTT, 4 REMARK 210 G/L [U-100% 13C] GLUCOSE, 1 G/L REMARK 210 AMMONIUM CHLORIDE, 0.5 MG/ML REMARK 210 MYRISTIC ACID, 50 MM SODIUM REMARK 210 PHOSPHATE, 150 MM SODIUM REMARK 210 CHLORIDE, 10 MM DTT, 4 G/L [U- REMARK 210 100% 13C] GLUCOSE, 1 G/L [U-99% REMARK 210 15N] AMMONIUM CHLORIDE, 0.5 MG/ REMARK 210 ML MYRISTIC ACID, 50 MM SODIUM REMARK 210 PHOSPHATE, 150 MM SODIUM REMARK 210 CHLORIDE, 10 MM DTT, 4 G/L REMARK 210 GLUCOSE, 1 G/L AMMONIUM CHLORIDE, REMARK 210 0.5 MG/ML MYRISTIC ACID, 100% REMARK 210 D2O; 50 MM SODIUM PHOSPHATE, 150 REMARK 210 MM SODIUM CHLORIDE, 10 MM DTT, 1 REMARK 210 G/L [U-99% 15N] AMMONIUM REMARK 210 CHLORIDE, 4 G/L GLUCOSE, 0.5 MG/ REMARK 210 ML MYRISTIC ACID, 50 MM SODIUM REMARK 210 PHOSPHATE, 150 MM SODIUM REMARK 210 CHLORIDE, 10 MM DTT, 1 G/L REMARK 210 AMMONIUM CHLORIDE, 4 G/L GLUCOSE, REMARK 210 0.5 MG/ML [U-100% 13C] MYRISTIC REMARK 210 ACID, 90% H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 15N-1HN HSQC; 13C-1HN HNCA; 13C REMARK 210 -1HN HN(CO)CA; CBCANH; CBCA(CO) REMARK 210 NH; CARBON-NITROGEN NOESY (CNNOE) REMARK 210 ; 15N EDITED 3D NOESY; 1H-13C REMARK 210 HMQC; CARBON CARBON NOSEY (CCNOE) REMARK 210 ; 1H-1H NOESY; 13C-1H HMQC NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRVIEW, CYANA, NMRPIPE, REMARK 210 NMRDRAW, TOPSPIN REMARK 210 METHOD USED : CYANA REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : 20 STRUCTURES FOR LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 5 -66.26 -138.56 REMARK 500 1 SER A 6 39.52 -144.12 REMARK 500 1 LYS A 26 88.08 53.47 REMARK 500 1 SER A 27 -56.86 -165.30 REMARK 500 1 ASP A 52 52.27 -144.39 REMARK 500 1 THR A 99 98.58 -59.68 REMARK 500 1 VAL A 100 -178.84 -57.47 REMARK 500 1 ARG A 118 71.41 -156.94 REMARK 500 1 GLU A 123 -62.83 -90.78 REMARK 500 1 GLU A 128 83.28 52.36 REMARK 500 2 ARG A 48 162.01 63.36 REMARK 500 2 GLU A 49 160.55 63.30 REMARK 500 2 ASP A 52 55.83 -150.28 REMARK 500 2 PRO A 54 -170.93 -69.77 REMARK 500 2 GLU A 55 -41.61 -156.94 REMARK 500 2 THR A 99 48.16 -108.21 REMARK 500 2 PRO A 119 84.12 -69.79 REMARK 500 2 LYS A 122 171.63 62.85 REMARK 500 2 LYS A 127 -174.38 58.71 REMARK 500 3 SER A 6 -72.19 -156.68 REMARK 500 3 ASN A 18 38.38 -94.82 REMARK 500 3 ARG A 48 128.82 -179.30 REMARK 500 3 GLU A 49 160.52 62.97 REMARK 500 3 PRO A 54 84.77 -69.78 REMARK 500 3 GLN A 133 90.98 54.59 REMARK 500 3 ALA A 134 -65.57 -146.40 REMARK 500 4 ASN A 3 63.05 -100.74 REMARK 500 4 ASN A 18 34.09 -95.63 REMARK 500 4 LYS A 26 38.70 -97.27 REMARK 500 4 ARG A 48 128.95 -179.41 REMARK 500 4 GLU A 49 160.60 62.94 REMARK 500 4 MET A 98 172.66 -56.38 REMARK 500 4 ARG A 118 71.62 -158.99 REMARK 500 4 MET A 121 118.80 -170.84 REMARK 500 4 GLU A 123 74.37 56.39 REMARK 500 4 GLU A 128 34.04 -168.85 REMARK 500 5 ALA A 5 103.00 -170.00 REMARK 500 5 LYS A 28 50.94 -111.00 REMARK 500 5 ASP A 52 53.71 -147.39 REMARK 500 5 PRO A 54 -171.01 -69.80 REMARK 500 5 GLU A 55 -39.82 -164.98 REMARK 500 5 ASP A 116 -171.29 58.42 REMARK 500 5 THR A 117 108.34 64.29 REMARK 500 5 SER A 120 106.21 -174.58 REMARK 500 5 MET A 121 32.20 -161.27 REMARK 500 5 LYS A 122 65.83 -163.98 REMARK 500 5 GLU A 128 139.40 -172.29 REMARK 500 5 ALA A 134 105.26 -172.94 REMARK 500 6 ASN A 18 36.97 -95.24 REMARK 500 6 LYS A 26 63.74 -118.80 REMARK 500 REMARK 500 THIS ENTRY HAS 197 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25573 RELATED DB: BMRB REMARK 999 REMARK 999 SEQUENCE REMARK 999 MYRISTYLATED DBREF 2N1R A 2 135 UNP P16087 GAG_FIVPE 2 135 SEQADV 2N1R MYR A 1 UNP P16087 MODIFIED RESIDUE SEQADV 2N1R ALA A 5 UNP P16087 GLN 5 ENGINEERED MUTATION SEQADV 2N1R SER A 6 UNP P16087 GLY 6 ENGINEERED MUTATION SEQRES 1 A 135 MYR GLY ASN GLY ALA SER ARG ASP TRP LYS MET ALA ILE SEQRES 2 A 135 LYS ARG CYS SER ASN VAL ALA VAL GLY VAL GLY GLY LYS SEQRES 3 A 135 SER LYS LYS PHE GLY GLU GLY ASN PHE ARG TRP ALA ILE SEQRES 4 A 135 ARG MET ALA ASN VAL SER THR GLY ARG GLU PRO GLY ASP SEQRES 5 A 135 ILE PRO GLU THR LEU ASP GLN LEU ARG LEU VAL ILE CYS SEQRES 6 A 135 ASP LEU GLN GLU ARG ARG GLU LYS PHE GLY SER SER LYS SEQRES 7 A 135 GLU ILE ASP MET ALA ILE VAL THR LEU LYS VAL PHE ALA SEQRES 8 A 135 VAL ALA GLY LEU LEU ASN MET THR VAL SER THR ALA ALA SEQRES 9 A 135 ALA ALA GLU ASN MET TYR SER GLN MET GLY LEU ASP THR SEQRES 10 A 135 ARG PRO SER MET LYS GLU ALA GLY GLY LYS GLU GLU GLY SEQRES 11 A 135 PRO PRO GLN ALA TYR HET MYR A 1 42 HETNAM MYR MYRISTIC ACID FORMUL 1 MYR C14 H28 O2 HELIX 1 1 SER A 6 SER A 17 1 12 HELIX 2 2 GLY A 31 THR A 46 1 16 HELIX 3 3 THR A 56 GLY A 75 1 20 HELIX 4 4 SER A 77 LEU A 96 1 20 HELIX 5 5 THR A 102 GLY A 114 1 13 LINK C1 MYR A 1 N GLY A 2 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 HETATM 1 C1 MYR A 1 -7.093 11.816 -4.533 1.00 54.15 C HETATM 2 O1 MYR A 1 -7.094 10.871 -5.321 1.00 41.12 O HETATM 3 C2 MYR A 1 -6.033 11.843 -3.431 1.00 54.23 C HETATM 4 C3 MYR A 1 -5.810 10.488 -2.721 1.00 60.34 C HETATM 5 C4 MYR A 1 -4.994 9.509 -3.585 1.00 61.55 C HETATM 6 C5 MYR A 1 -3.882 8.811 -2.780 1.00 5.11 C HETATM 7 C6 MYR A 1 -3.808 7.301 -3.076 1.00 3.12 C HETATM 8 C7 MYR A 1 -2.647 6.618 -2.328 1.00 71.54 C HETATM 9 C8 MYR A 1 -1.392 6.472 -3.210 1.00 31.43 C HETATM 10 C9 MYR A 1 -1.315 5.091 -3.890 1.00 15.54 C HETATM 11 C10 MYR A 1 -0.017 4.337 -3.536 1.00 32.14 C HETATM 12 C11 MYR A 1 0.002 3.739 -2.113 1.00 5.52 C HETATM 13 C12 MYR A 1 0.916 2.506 -1.954 1.00 3.41 C HETATM 14 C13 MYR A 1 0.892 1.944 -0.522 1.00 33.10 C HETATM 15 C14 MYR A 1 0.892 0.409 -0.512 1.00 14.12 C HETATM 16 H21 MYR A 1 -6.356 12.599 -2.691 1.00 25.31 H HETATM 17 H22 MYR A 1 -5.081 12.233 -3.837 1.00 53.25 H HETATM 18 H31 MYR A 1 -6.785 10.032 -2.458 1.00 53.23 H HETATM 19 H32 MYR A 1 -5.292 10.656 -1.755 1.00 63.34 H HETATM 20 H41 MYR A 1 -4.549 10.050 -4.444 1.00 25.22 H HETATM 21 H42 MYR A 1 -5.666 8.748 -4.029 1.00 74.21 H HETATM 22 H51 MYR A 1 -4.046 8.971 -1.696 1.00 55.51 H HETATM 23 H52 MYR A 1 -2.905 9.283 -3.005 1.00 42.54 H HETATM 24 H61 MYR A 1 -3.696 7.139 -4.166 1.00 41.12 H HETATM 25 H62 MYR A 1 -4.766 6.818 -2.799 1.00 43.13 H HETATM 26 H71 MYR A 1 -2.969 5.620 -1.970 1.00 33.05 H HETATM 27 H72 MYR A 1 -2.398 7.196 -1.417 1.00 24.34 H HETATM 28 H81 MYR A 1 -0.484 6.637 -2.597 1.00 10.31 H HETATM 29 H82 MYR A 1 -1.382 7.268 -3.980 1.00 44.00 H HETATM 30 H91 MYR A 1 -1.391 5.215 -4.987 1.00 73.53 H HETATM 31 H92 MYR A 1 -2.192 4.480 -3.598 1.00 54.51 H HETATM 32 H101 MYR A 1 0.838 5.034 -3.632 1.00 23.21 H HETATM 33 H102 MYR A 1 0.179 3.540 -4.280 1.00 41.41 H HETATM 34 H111 MYR A 1 -1.030 3.496 -1.793 1.00 61.44 H HETATM 35 H112 MYR A 1 0.340 4.526 -1.410 1.00 14.21 H HETATM 36 H121 MYR A 1 1.954 2.773 -2.234 1.00 42.33 H HETATM 37 H122 MYR A 1 0.610 1.717 -2.667 1.00 61.21 H HETATM 38 H131 MYR A 1 0.000 2.318 0.018 1.00 35.31 H HETATM 39 H132 MYR A 1 1.764 2.318 0.049 1.00 22.33 H HETATM 40 H141 MYR A 1 0.892 0.000 -1.539 1.00 74.02 H HETATM 41 H142 MYR A 1 1.783 0.000 0.000 1.00 1.00 H HETATM 42 H143 MYR A 1 0.000 0.000 0.000 1.00 0.00 H